Cevimeline Hydrochloride Capsule
Product Images NDC 0713-0937

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cevimeline Hydrochloride (NDC 0713-0937). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cosette Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula For Cevimeline Is Cis -2’-methylspiro{1-azabicyclo [2.2.2] Octane-3, 5’-[1,3] Oxathiolane} Hydrochloride, Hydrate (2:1). Its Empirical Formula Is C10h17nos.hcl. (Cevimeline 01)

Chemical structure of cevimeline hydrochloride showing its molecular configuration with specific heteroatoms and functional groups, including a tetrahydroazepine ring, a thioether linkage, and an acetal group, along with associated hydrochloride and water of hydration components.*

FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Label)

Label for Cevimeline Hydrochloride Capsules 30 mg, oral dosage form, showing a package size of 100 capsules. The label features the manufacturer Cosette Pharmaceuticals, Inc., with storage instructions and a barcode. The NDC is 0713-0937-01. The label indicates prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.